For cancer patients and their loved ones, days, weeks, and months matter. In fact, anyone who has waited anxiously for test results or a treatment regimen to begin can attest that hours, or even minutes, will drag on with emotional heaviness. From a clinical standpoint as well, time to treatment significantly impacts outcomes. All suspected cancers should be ruled out or confirmed with a diagnosis so treatment can begin as soon as possible. Similarly, patients with incidental findings—masses or
Read More
Oncology Technology Solutions, Services Impacting Patients and Providers
Nectin Therapeutics Raises $25M for Immuno-Oncology Therapies
What You Should Know:
- Nectin Therapeutics Ltd., (Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved immune-oncology treatments, announced it has extended its Series A financing to over $25 million. IBF and Peregrine Ventures led the round, with participation from aMoon Fund and other existing investors.
- The funding will be used to support the ongoing clinical evaluation of NTX1088, and to further advance the company’s pipeline of
Read More
RSNA: Philips Unveils AI-Enhanced Informatics Solutions to Optimize Radiology Workflow
What You Should Know:
- Today at RNSA22, Philips unveils its next-generation Advanced Visualization Workspace, including new cardiac MR Suite with new workflow and user interface, new AI powered CT ASPECT Scoring, and enhanced CT Liver Analysis applications.
- New integrated diagnostic approach connects radiology, cardiology, pathology, and oncology to securely unite data and images across the enterprise, enabling earlier and more definitive diagnosis. Optimized algorithms help speed up
Read More
HLTH22 Day 3 News Summary
DispatchHealth Raises $330M for Hospital-at-Home Care
DispatchHealth, a provider of in-home medical care raises $330M led by Optum Ventures with support from current investors such as Humana (NYSE: HUM), Oak HC/FT, Echo Health Ventures and Questa Capital. New investors included Adams Street Partners, the Olayan Group, Silicon Valley Bank, Pegasus Tech Ventures and Blue Shield of California. Patients and their care partners can request DispatchHealth medical care via phone, mobile app, or
Read More
Haystack Oncology Launches with $56M for Post-Op Cancer Detection Tech
What You Should Know:
- Haystack Oncology ("Haystack"), an oncology company that applies the next generation of circulating tumor DNA (ctDNA) detection technology raises $56M in Series A financing led by Catalio Capital Management ("Catalio"), which co-founded Haystack through its private equity and structured equity investment vehicles. Additional investors include Bruker, Exact Ventures, the venture arm of Exact Sciences and Alexandria Venture
Read More
ConcertAI Names Ronan Brown as its First COO
What You Should Know:
- ConcertAI, which provides AI SaaS and real-world data tech solutions for oncology research and trials, today announced the appointment of Ronan Brown as its first COO.
- In his new role as COO, Brown will oversee and enhance day-to-day operations across the company, globally, to assure the quality, performance, and seamless functionality of the company’s solutions as the ConcertAI continues it high growth.
- Brown, who was most recently senior vice
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere.
Curavit Raises $5M for Digital Therapeutics
Read More
HLTH22: COTA and Google Partner to Use NLP to Harness Unstructured Oncology Data
What You Should Know:
COTA, Inc., an oncology real-world data and analytics company announced a partnership with Google Cloud to bring clarity to unstructured oncology data through the latest advancements in machine learning and natural language processing.
- Many leading real-world data companies - including COTA - leverage clinicians to manually curate oncology real-world data. While this is a reliable and trusted near-term solution to overcoming the challenges associated with
Read More
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More
JPMorgan Establishes Life Sciences Private Equity Division
What You Should Know:
- J.P. Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital.
- The new team will focus on investing in both early and growth-stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity,
Read More
